Published in Virology on July 30, 1983
Dengue: the risk to developed and developing countries. Proc Natl Acad Sci U S A (1994) 7.76
The dengue viruses. Clin Microbiol Rev (1990) 4.72
Molecular and epidemiologic analysis of dengue virus isolates from Somalia. Emerg Infect Dis (1998) 1.77
Identification of amino acids involved in recognition by dengue virus NS3-specific, HLA-DR15-restricted cytotoxic CD4+ T-cell clones. J Virol (1996) 1.28
Genetic diversity of the E protein of dengue type 3 virus. Virol J (2009) 1.15
RNA fingerprinting of respiratory syncytial virus using ribonuclease protection. Application to molecular epidemiology. J Clin Invest (1989) 1.03
The distribution of synonymous codon choice in the translation initiation region of dengue virus. PLoS One (2013) 0.91
Dengue virus markers of virulence and pathogenicity. Future Virol (2009) 0.83
Genetic heterogeneity among isolates of Ross River virus from different geographical regions. J Virol (1993) 0.80
Detection of bovine viral diarrhea virus genome in leukocytes from persistently infected cattle by RNA-cDNA hybridization. Can J Vet Res (1990) 0.76
Phylogenetic analysis of the envelope protein (domain III) of dengue 4 viruses. Salud Publica Mex (2002) 0.75
Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology (1997) 9.70
The use of mosquitoes to detect and propagate dengue viruses. Am J Trop Med Hyg (1974) 5.56
Molecular evolution and epidemiology of dengue-3 viruses. J Gen Virol (1994) 4.47
Nucleotide sequence and deduced amino acid sequence of the structural proteins of dengue type 2 virus, Jamaica genotype. Virology (1986) 4.34
Lassa virus isolation from Mastomys natalensis rodents during an epidemic in Sierra Leone. Science (1974) 3.86
A hospital epidemic of Lassa fever in Zorzor, Liberia, March-April 1972. Am J Trop Med Hyg (1973) 3.71
Molecular evolution and phylogeny of dengue-4 viruses. J Gen Virol (1997) 3.30
Identification of epitopes on the E glycoprotein of Saint Louis encephalitis virus using monoclonal antibodies. Virology (1983) 3.24
Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases. Lancet (2001) 3.09
Epidemiologic, clinical, and virologic observations on dengue in the Kingdom of Tonga. Am J Trop Med Hyg (1978) 3.08
Emergence of epidemic dengue/dengue hemorrhagic fever as a public health problem in the Americas. Infect Agents Dis (1993) 3.07
Flaviviridae. Intervirology (1985) 3.06
A simple technique for the detection of dengue antigen in mosquitoes by immunofluorescence. Am J Trop Med Hyg (1977) 3.04
Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. II. Clinical observations and virological studies on selected hospital cases. Am J Trop Med Hyg (1974) 2.95
Immunoglobulin M antibody capture enzyme-linked immunosorbent assay for diagnosis of St. Louis encephalitis. J Clin Microbiol (1984) 2.95
Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology (1999) 2.72
The full-length nucleotide sequences of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and its attenuated vaccine derivative, strain TC-83. Virology (1989) 2.72
Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J Exp Med (1998) 2.70
Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein. J Virol (1993) 2.69
Biochemical and genetic studies on two different types of erythromycin resistant mutants of Escherichia coli with altered ribosomal proteins. Mol Gen Genet (1973) 2.59
Hereditary angioedema: its diagnostic and management perspectives. Am J Med (1990) 2.50
A habitable fluvio-lacustrine environment at Yellowknife Bay, Gale crater, Mars. Science (2013) 2.50
The Emperor's New Clothes revisited, or reflections on the pathogenesis of dengue hemorrhagic fever. Am J Trop Med Hyg (1977) 2.41
Spina bifida outcome: a 25-year prospective. Pediatr Neurosurg (2001) 2.38
Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine. Bull World Health Organ (1981) 2.36
Lassa fever. Trop Doct (1973) 2.32
Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1. J Virol (1986) 2.26
Introducing a drug formulary to general practice--effects on practice prescribing costs. J R Coll Gen Pract (1987) 2.24
Nucleotide sequence and deduced amino acid sequence of the nonstructural proteins of dengue type 2 virus, Jamaica genotype: comparative analysis of the full-length genome. Virology (1988) 2.22
Novel alpha2-adrenoreceptors primarily responsible for inducing human platelet aggregation. Nature (1979) 2.17
Phylogenetic relationships of dengue-2 viruses. Virology (1993) 2.16
Polymorphism of the migration of double-stranded RNA genome segments of reovirus isolates from humans, cattle, and mice. J Virol (1979) 2.15
Quantitative evaluation of a screening program. Am J Public Health (1974) 2.00
Review of postoperative CT and ultrasound for endovascular aneurysm repair using Talent stent graft: can we simplify the surveillance protocol and reduce the number of CT scans? Acta Radiol (2013) 1.99
Variation among geographic strains of Aedes albopictus in susceptibility to infection with dengue viruses. Am J Trop Med Hyg (1976) 1.99
Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis. J Infect Dis (1995) 1.97
Togaviridae. Intervirology (1985) 1.96
Partial nucleotide sequence of the Murray Valley encephalitis virus genome. Comparison of the encoded polypeptides with yellow fever virus structural and non-structural proteins. J Mol Biol (1986) 1.96
Growth-restricted dengue virus mutants containing deletions in the 5' noncoding region of the RNA genome. Virology (1995) 1.95
Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. I. Epidemiologic studies. Am J Trop Med Hyg (1974) 1.92
The 3'-non-coding regions of alphavirus RNAs contain repeating sequences. J Mol Biol (1982) 1.92
Clinical presentation of Lassa fever cases during the hospital epidemic at Zorzor, Liberia, March-April 1972. Am J Trop Med Hyg (1973) 1.91
Lassa fever: review of epidemiology and epizootiology. Bull World Health Organ (1975) 1.86
Therapeutic immunization against Helicobacter mustelae in naturally infected ferrets. Gastroenterology (1996) 1.84
Nucleotide sequence of the 26 S mRNA of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and deduced sequence of the encoded structural proteins. Virology (1986) 1.84
Infectious Japanese encephalitis virus RNA can be synthesized from in vitro-ligated cDNA templates. J Virol (1992) 1.82
A simple technique for demonstrating transmission of dengue virus by mosquitoes without the use of vertebrate hosts. Am J Trop Med Hyg (1976) 1.81
Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates. J Virol (2000) 1.79
The 1970 yellow fever epidemic in Okwoga District, Benue Plateau State, Nigeria. 3. Serological responses in persons with and without pre-existing heterologous group B immunity. Bull World Health Organ (1973) 1.79
Electrophoretic and immunological studies on ribosomal proteins of 100 Escherichia coli revertants from streptomycin dependence. Mol Gen Genet (1973) 1.78
Genetic determinants of dengue type 4 virus neurovirulence for mice. J Virol (1993) 1.78
Increased MCP-1, RANTES, and MIP-1alpha in bronchoalveolar lavage fluid of allergic asthmatic patients. Am J Respir Crit Care Med (1996) 1.75
Fatal hemorrhagic disease and shock associated with primary dengue infection on a Pacific island. Am J Trop Med Hyg (1974) 1.74
Variation among goegraphic strains of Aedes albopictus in susceptibility to infection with chikungunya virus. Am J Trop Med Hyg (1976) 1.74
Contribution of general practitioner hospitals in Scotland. Br Med J (Clin Res Ed) (1984) 1.74
Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine. J Virol (2001) 1.73
Histamine-releasing activity (HRA). I. Production by mitogen- or antigen-stimulated human mononuclear cells. J Immunol (1979) 1.72
Lassa fever in Britain: an imported case. Br Med J (1973) 1.72
A closer look at water-related geologic activity on Mars. Science (2007) 1.71
The natural history of Japanese encephalitis virus. Annu Rev Microbiol (1986) 1.70
Rationale, design and methods for process evaluation in the HEALTHY study. Int J Obes (Lond) (2009) 1.70
A comparison of the nucleotide sequences of eastern and western equine encephalomyelitis viruses with those of other alphaviruses and related RNA viruses. Virology (1993) 1.67
Identification of monoclonal antibodies capable of differentiating antigenic varieties of eastern equine encephalitis viruses. Am J Trop Med Hyg (1990) 1.66
Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils. J Clin Invest (1992) 1.66
Volatile and organic compositions of sedimentary rocks in Yellowknife Bay, Gale crater, Mars. Science (2013) 1.65
Nucleotide sequence of the genome region encoding the 26S mRNA of eastern equine encephalomyelitis virus and the deduced amino acid sequence of the viral structural proteins. J Gen Virol (1987) 1.65
Non-specificity of anti-HCV test for seroepidemiological analysis. Lancet (1990) 1.62
Value of carcinoembryonic antigen monitoring in curative surgery for recurrent colorectal carcinoma. Dis Colon Rectum (1997) 1.61
Lassa fever and Marburg virus disease. WHO Chron (1974) 1.58
Community hospitals--time to come off the fence. J R Coll Gen Pract (1989) 1.57
Endorectal repair of rectocele revisited. Br J Surg (1997) 1.57
Challenge model for Helicobacter pylori infection in human volunteers. Gut (2004) 1.57
Transovarial transmission of dengue viruses by mosquitoes: Aedes albopictus and Aedes aegypti. Am J Trop Med Hyg (1983) 1.56
Mode of entry of a neurotropic arbovirus into the central nervous system. Reinvestigation of an old controversy. Lab Invest (1983) 1.55
Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection. Infect Immun (1998) 1.54
Nucleotide sequence of the virulent SA-14 strain of Japanese encephalitis virus and its attenuated vaccine derivative, SA-14-14-2. Virology (1990) 1.52
Hydrated silicate minerals on Mars observed by the Mars Reconnaissance Orbiter CRISM instrument. Nature (2008) 1.52
Refractory cholinergic urticaria successfully treated with ketotifen. J Allergy Clin Immunol (1989) 1.52
Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases. Blood (2000) 1.51
Labile serum factor and its effect on arbovirus neutralization. Appl Microbiol (1971) 1.51
Detection of yellow fever virus in serum by enzyme immunoassay. Am J Trop Med Hyg (1984) 1.50
RANTES is a chemotactic and activating factor for human eosinophils. J Immunol (1993) 1.49
Arthropod-borne encephalitides in the Americas. Bull World Health Organ (1979) 1.47
Hyperplastic polyps: "more than meets the eye"? Report of sixteen cases. Dis Colon Rectum (2000) 1.47
Neutralizing antibody responses in the major immunoglobulin classes to yellow fever 17D vaccination of humans. Am J Epidemiol (1971) 1.45
Life history of the canine lungworm Angiostrongylus vasorum (Baillet). Am J Vet Res (1970) 1.44
Clinical and laboratory observations on patients with primary and secondary dengue type 1 infections with hemorrhagic manifestations in Fiji. Am J Trop Med Hyg (1977) 1.44
Comparative susceptibility of mosquito species and strains to oral and parenteral infection with dengue and Japanese encephalitis viruses. Am J Trop Med Hyg (1985) 1.44
Antiviral (RNA) activity of selected Amaryllidaceae isoquinoline constituents and synthesis of related substances. J Nat Prod (1992) 1.43
Respiratory viruses induce production of histamine-releasing factor by mononuclear leukocytes: a possible role in the mechanism of virus-induced asthma. J Infect Dis (1991) 1.43
Epidemic yellow fever caused by an incompetent mosquito vector. Trop Med Parasitol (1989) 1.43
Structural and nonstructural proteins of Saint Louis encephalitis virus. J Virol (1971) 1.43
Urban yellow fever epidemic in western Nigeria, 1987. Trans R Soc Trop Med Hyg (1990) 1.41
Molecular epidemiology of dengue-1 and dengue-4 viruses. J Gen Virol (1995) 1.40
Monstrous, crablike hypertrophy of the cerebellar vermis and its relationship with Lhermitte-Duclos disease. Case report. J Neurosurg (1996) 1.39
Experimental infection of chimpanzees with dengue viruses. Am J Trop Med Hyg (1978) 1.39